Merck cites EnWave's REV™ Technology as a Faster, Viable Drying Alternative to Vial-Based ...

Retrieved on: 2021-01-26 14:02:25

Tags for this article:

Click the tags to see associated articles and topics

Merck cites EnWave's REV™ Technology as a Faster, Viable Drying Alternative to Vial-Based .... View article details on hiswai:

Excerpt

VANCOUVER, British Columbia, Jan. 26, 2021 (GLOBE NEWSWIRE) --. EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the “Company”) ...

Article found on: www.globenewswire.com